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Enterovirus D68 (EV-D68), a member of the enterovirus D species of the family *Picornaviridae*, is a single stranded, positive-sense RNA virus with an \~7.3-kb genome ([@B1], [@B2]). Its genome comprises a 5′ untranslated region (5′-UTR), structural polypeptide P1, nonstructural polypeptides P2 and P3, and a 3′ untranslated region (3′-UTR). P1, P2, and P3 are cleaved into four structural proteins (VP1 to VP4), three nonstructural proteins (2A to 2C), and four nonstructural proteins (3A to 3D), respectively. EV-D68 was originally isolated from four American children with respiratory illness in 1962 ([@B3]). Since then, EV-D68 had not caused public concern until its outbreaks in the United States in the second half of 2014 ([@B4][@B5][@B7]). Subsequently, some retrospective and field epidemiological investigations on the prevalence of EV-D68 associated with respiratory infections were successively reported in different geographic regions ([@B8][@B9][@B10]). These data have demonstrated an increasing number of patients with EV-D68 infections and the wide spread of EV-D68 across the world in recent years.

Between 16 November 2015 and 16 December 2015, four EV-D68 strains from four children with influenza-like illness were identified by real-time reverse transcription PCR and sequencing of VP1 genes in Shenzhen, southern China ([@B11]). Next, two sets of primers pairs, EVD68-1F21 (TTAAAACAGCTCTGGGGTTGT)/EVD68-4570R27 (ATTTTGCATTAAATCATCCATAAGGAC) and EVD68-4394F26 (TCAAGTCCAAATCTCGCATTGAACCG)/EVD68-7340R27 (GTCCCCAAGTGACCAAAATTTACCTCT), were designed to amplify two overlapping fragments encompassing the complete genome of EV-D68. Amplified DNA products were sequenced by TaKaRa using a primer-walking method. The two overlapping fragments were assembled into a complete genome using Lasergene version 7.1. The assembled genome sequences were examined using BioEdit version 7.2.5 before submission to GenBank.

The complete genome sequences of the four EV-D68 strains from the study were composed of 7,293 nucleotides (nt), excluding the poly(A) tail. The 5′-UTR contains 699 nt, followed by an open reading frame encoding the structural protein P1 (2,583 nt), the nonstructural proteins P2 (1,728 nt) and P3 (2,253 nt), and the 3′-UTR (27 nt). The base compositions of the full genomes of the four EV-D68 strains are 31.58 to 31.67% A, 20.35 to 20.47% C, 21.34 to 21.42% G, and 26.53 to 26.64% U. The complete nucleotide sequences and complete amino acid sequences (2,188 aa) of the four EV-D68 strains showed 0 to 2.9% and 0 to 0.8% differences to each other, respectively. No sequence insertion or deletion was observed in the complete genome region of the four EV-D68 strains compared to the closest known strains. Genome-wide sequence analysis indicated that these four EV-D68 strains belonged to the latest clade comprising some sporadic strains from China.

Recent EV-D68 strains have evolved worldwide into distinct clades, which shows the trend of further geographical spread ([@B6], [@B12][@B13][@B18]). Since there is no epidemiological data on EV-D68 infections in southern China at present, this study urges us to investigate the prevalence of EV-D68 as quickly as possible and strengthen surveillance of EV-D68 to prevent its outbreak.
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The complete genome sequences of four EV-D68 strains from the present study have been deposited in GenBank under the accession numbers [KU982558](http://www.ncbi.nlm.nih.gov/nuccore/KU982558) to [KU982561](http://www.ncbi.nlm.nih.gov/nuccore/KU982561).
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